|
|
||||||||
Ann Thorac Surg 2004;77:1183-1188
© 2004 The Society of Thoracic Surgeons
a Department of Oncological and Regenerative Surgery, School of Medicine, University of Tokushima, Tokushima, Japan
c Department of Surgery, Tokushima Municipal Hospital, Tokushima, Japan
d Department of Surgery, Tokushima Red Cross Hospital, Tokushima, Japan
e Department of Surgery, Tokushima Prefectural Central Hospital, Tokushima, Japan
b Department of Surgery, Takamatsu Red Cross Hospital, Takamatsu, Japan
f First Department of Pathology, Tokyo Medical University, Tokyo, Japan
Accepted for publication July 17, 2003.
* Address reprint requests to Dr Kondo, Dept of Oncological and Regenerative Surgery, School of Medicine, University of Tokushima, Kuramoto-cho, Tokushima 770-8503, Japan
e-mail: kondo{at}clin.med.tokushima-u.ac.jp
BACKGROUND: The histologic classification of thymoma has remained a subject of controversy for many years. In 1999, the World Health Organization Consensus Committee published a histologic typing system for tumors of the thymus.
METHODS: We reclassified a series of 100 thymomas resected at Tokushima University Hospital and four affiliated hospitals in Japan between 1973 and 2001 according to the World Health Organization histologic classification and reported its clinicopathologic relationship and prognostic relevance.
RESULTS: There were 8 type A, 17 type AB, 27 type B1, 8 type B2, 12 type B3, and 28 type C thymomas. The frequency of invasion to neighboring organs increased according to tumor subtype in the order A (0%), AB (6%), B1 (19%), B2 (25%), B3 (42%), and C (89%). There was no recurrence in patients with type A, AB, or B2 thymoma. The recurrence rates of patients with B1, B3, or C thymoma were 15%, 36%, and 47%, respectively. The disease-free survival rates were 100% for types A and AB, 83% for types B1 and B2, 36% for type B3, and 28% for type C thymoma at 10 years. There were significant differences in disease-free survival between types A and AB and types B1 and B2 (p = 0.0436), and between type B3 and type C (p = 0.042). By multivariate analysis, only Masaoka clinical stage (p = 0.002) showed significant independent effects on disease-free survival. The 10-year survival rates of types A and AB, types B1 and B2, type B3, and type C thymoma were 100%, 94%, 92%, and 58%, respectively.
CONCLUSIONS: The current study confirmed the World Health Organization histologic classification as a good prognostic factor.
This article has been cited by other articles:
![]() |
E. Davenport and R. A. Malthaner The role of surgery in the management of thymoma: a systematic review. Ann. Thorac. Surg., August 1, 2008; 86(2): 673 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lucchi, F. Basolo, and A. Mussi Surgical treatment of pleural recurrence from thymoma Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 707 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rena, E. Papalia, A. Oliaro, E. Ruffini, P. Filosso, D. Novero, G. Maggi, and C. Casadio Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 109 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Suster Diagnosis of thymoma J. Clin. Pathol., December 1, 2006; 59(12): 1238 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Riedel and W. R. Burfeind Jr Thymoma: Benign Appearance, Malignant Potential Oncologist, September 1, 2006; 11(8): 887 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Detterbeck Clinical Value of the WHO Classification System of Thymoma Ann. Thorac. Surg., June 1, 2006; 81(6): 2328 - 2334. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Bedini, S. M. Andreani, L. Tavecchio, A. Fabbri, R. Giardini, T. Camerini, R. Bufalino, A. Morabito, and J. Rosai Proposal of a Novel System for the Staging of Thymic Epithelial Tumors Ann. Thorac. Surg., December 1, 2005; 80(6): 1994 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fang, W. Chen, G. Chen, and Y. Jiang Surgical Management of Thymic Epithelial Tumors: A Retrospective Review of 204 Cases Ann. Thorac. Surg., December 1, 2005; 80(6): 2002 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Wright, J. C. Wain, D. R. Wong, D. M. Donahue, H. A. Gaissert, H. C. Grillo, and D. J. Mathisen Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1413 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zisis, D. Rontogianni, C. Tzavara, K. Stefanaki, A. Chatzimichalis, A. Loutsidis, K. Iliadis, A. Kontaxis, T. Dosios, and I. Bellenis Prognostic Factors in Thymic Epithelial Tumors Undergoing Complete Resection Ann. Thorac. Surg., September 1, 2005; 80(3): 1056 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lucchi, M. C. Ambrogi, L. Duranti, F. Basolo, G. Fontanini, C. A. Angeletti, and A. Mussi Advanced Stage Thymomas and Thymic Carcinomas: Results of Multimodality Treatments Ann. Thorac. Surg., June 1, 2005; 79(6): 1840 - 1844. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |